Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial
Background: Encrustation of ureteral double J stents is a common complication that may affect its removal. The aim of the proposed study is to evaluate the efficacy and safety of a new oral composition to prevent double J stent encrustation in indwelling times up to 8 weeks. Methods: A double-blinde...
| Autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/173615 |
| Acceso en línea: | https://hdl.handle.net/2445/173615 |
| Access Level: | acceso abierto |
| Palabra clave: | Urèter Anàlisi d'orina Ureters Urine analysis |
| id |
ES_e22950fcdff85e40a9f96bef9ecdb39c |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/173615 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trialTorrecilla, CarlosFernández Concha, JaimeCansino, José R.Mainez, Juan A.Amón, José H.Costas, SimbadAngerri, OriolEmiliani, EstebanArrabal Martín, Miguel A.Arrabal Polo, Miguel A.García, AnaReina, Manuel C.Sánchez, Juan F.Budía, AlbertoPérez Fentes, DanielGrases, FélixCosta Bauzá, AntoniaCuñé, JordiUrèterAnàlisi d'orinaUretersUrine analysisBackground: Encrustation of ureteral double J stents is a common complication that may affect its removal. The aim of the proposed study is to evaluate the efficacy and safety of a new oral composition to prevent double J stent encrustation in indwelling times up to 8 weeks. Methods: A double-blinded, multicenter, placebo-controlled trial was conducted with 105 patients with indwelling double J stents enrolled across 9 public hospitals in Spain. The patients were randomly assigned (1:1) into intervention (53 patients) or placebo (52 patients) groups for 3 to 8 weeks and both groups self-monitored daily their morning urine pH levels. The primary outcome of analysis was the degree of stent ends encrustation, defined by a 4-point score (0 - none; 3 - global encrustation) using macroscopic and electron microscopy analysis of crystals, after 3 to 8-w indwelling period. Score was exponentially transformed according to calcium levels. Secondary endpoints included urine pH decrease, stent removal, and incidence of adverse events. Results: The intervention group benefits from a lower global encrustation rate of stent ends than placebo group (1% vs 8.2%; p < 0.018). Mean encrustation score was 85.12 (274.5) in the placebo group and 18.91 (102.27) in the intervention group (p < 0.025). Considering the secondary end points, treated patients reported greater urine pH decreases (p = 0.002). No differences in the incidence of adverse events were identified between the groups. Conclusions: Our data suggest that the use of this new oral composition is beneficial in the context of ureteral double J indwelling by decreasing mean, as well as global encrustation.BioMed Central2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/173615Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1186/s12894-020-00633-2BMC Urology, 2020, vol. 20https://doi.org/10.1186/s12894-020-00633-2cc by (c) Torrecilla et al., 2020http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1736152026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial |
| title |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial |
| spellingShingle |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial Torrecilla, Carlos Urèter Anàlisi d'orina Ureters Urine analysis |
| title_short |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial |
| title_full |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial |
| title_fullStr |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial |
| title_full_unstemmed |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial |
| title_sort |
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial |
| dc.creator.none.fl_str_mv |
Torrecilla, Carlos Fernández Concha, Jaime Cansino, José R. Mainez, Juan A. Amón, José H. Costas, Simbad Angerri, Oriol Emiliani, Esteban Arrabal Martín, Miguel A. Arrabal Polo, Miguel A. García, Ana Reina, Manuel C. Sánchez, Juan F. Budía, Alberto Pérez Fentes, Daniel Grases, Félix Costa Bauzá, Antonia Cuñé, Jordi |
| author |
Torrecilla, Carlos |
| author_facet |
Torrecilla, Carlos Fernández Concha, Jaime Cansino, José R. Mainez, Juan A. Amón, José H. Costas, Simbad Angerri, Oriol Emiliani, Esteban Arrabal Martín, Miguel A. Arrabal Polo, Miguel A. García, Ana Reina, Manuel C. Sánchez, Juan F. Budía, Alberto Pérez Fentes, Daniel Grases, Félix Costa Bauzá, Antonia Cuñé, Jordi |
| author_role |
author |
| author2 |
Fernández Concha, Jaime Cansino, José R. Mainez, Juan A. Amón, José H. Costas, Simbad Angerri, Oriol Emiliani, Esteban Arrabal Martín, Miguel A. Arrabal Polo, Miguel A. García, Ana Reina, Manuel C. Sánchez, Juan F. Budía, Alberto Pérez Fentes, Daniel Grases, Félix Costa Bauzá, Antonia Cuñé, Jordi |
| author2_role |
author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Urèter Anàlisi d'orina Ureters Urine analysis |
| topic |
Urèter Anàlisi d'orina Ureters Urine analysis |
| description |
Background: Encrustation of ureteral double J stents is a common complication that may affect its removal. The aim of the proposed study is to evaluate the efficacy and safety of a new oral composition to prevent double J stent encrustation in indwelling times up to 8 weeks. Methods: A double-blinded, multicenter, placebo-controlled trial was conducted with 105 patients with indwelling double J stents enrolled across 9 public hospitals in Spain. The patients were randomly assigned (1:1) into intervention (53 patients) or placebo (52 patients) groups for 3 to 8 weeks and both groups self-monitored daily their morning urine pH levels. The primary outcome of analysis was the degree of stent ends encrustation, defined by a 4-point score (0 - none; 3 - global encrustation) using macroscopic and electron microscopy analysis of crystals, after 3 to 8-w indwelling period. Score was exponentially transformed according to calcium levels. Secondary endpoints included urine pH decrease, stent removal, and incidence of adverse events. Results: The intervention group benefits from a lower global encrustation rate of stent ends than placebo group (1% vs 8.2%; p < 0.018). Mean encrustation score was 85.12 (274.5) in the placebo group and 18.91 (102.27) in the intervention group (p < 0.025). Considering the secondary end points, treated patients reported greater urine pH decreases (p = 0.002). No differences in the incidence of adverse events were identified between the groups. Conclusions: Our data suggest that the use of this new oral composition is beneficial in the context of ureteral double J indwelling by decreasing mean, as well as global encrustation. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/173615 |
| url |
https://hdl.handle.net/2445/173615 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.1186/s12894-020-00633-2 BMC Urology, 2020, vol. 20 https://doi.org/10.1186/s12894-020-00633-2 |
| dc.rights.none.fl_str_mv |
cc by (c) Torrecilla et al., 2020 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc by (c) Torrecilla et al., 2020 http://creativecommons.org/licenses/by/3.0/es/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
BioMed Central |
| publisher.none.fl_str_mv |
BioMed Central |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869422360310841344 |
| score |
15,300719 |